Virus therapy joins Chemo-Radiation in fight against rectal cancer
Disease control
Recruiting now
This early-phase trial tests a new treatment called NG-350A, a virus designed to stimulate the immune system inside tumors, combined with standard chemoradiotherapy for people with locally advanced rectal cancer. The study aims to see if this combination can improve the chance of…
Phase: PHASE1 • Sponsor: Akamis Bio • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC